• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB1200127 注射用阿加糖酶beta agalsidase beta Lyophilized Biological Products Supplementary Application 2012-05-23 Genzyme Corporation Genzyme Corporation;Hospira Inc Certificate Issued 2013-11-21 view
JYSB1200128 注射用阿加糖酶beta agalsidase beta Lyophilized Biological Products Supplementary Application 2012-05-23 Genzyme Corporation Genzyme Corporation;Hospira Inc Certificate Issued 2013-11-21 view
JXSS1800022 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Import Drug Application 2018-10-18 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV Certificate Issued 2019-12-23 view
JYSB2200061 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2022-03-30 Genzyme Ireland Ltd;Genzyme Europe BV view
JXSL0800014 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Import Drug Application 2008-06-13 Genzyme Corporation Genzyme Corporation Certificate Issued 2009-05-27 view
JYSB2000346 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2020-07-06 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV Certificate Issued 2020-10-27 view
JYSB2500046 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2025-02-26 Sanofi BV;Genzyme Ireland Ltd view
JYSB2101042 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2021-06-02 Genzyme Ireland Ltd;Genzyme Europe BV view
JYSB2000279 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2020-06-19 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV Filed 2020-06-22 view
JYSZ2300057 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products License Renew 2023-12-28 Sanofi BV;Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd view
JYSB2000278 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2020-06-19 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV Filed 2020-06-22 view
JYSZ2300056 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products License Renew 2023-12-28 Sanofi BV;Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd view
JYSB2101043 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2021-06-02 Genzyme Ireland Ltd;Genzyme Europe BV view
JXSS1800021 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Import Drug Application 2018-10-18 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV Certificate Issued 2019-12-23 view
JYSB2200062 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2022-03-30 Genzyme Ireland Ltd;Genzyme Europe BV view
JXSL0800013 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Import Drug Application 2008-06-18 Genzyme Corporation Genzyme Corporation Certificate Issued 2009-05-27 view
JYSB2000348 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2020-07-06 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV Certificate Issued 2020-10-27 view
JYSB2500045 注射用阿加糖酶β agalsidase beta Lyophilized Biological Products Supplementary Application 2025-02-26 Sanofi BV;Genzyme Ireland Ltd view